Industry Insights
Gene Therapy a New Paradigm for Healthcare: An Interview With bluebird bio
Industry Insight Technology Networks recently spoke with Martin Butzal, Head of Medical Europe at bluebird bio, to learn more about the exciting developments and key trends in the gene therapy space.
Making Allogeneic Cell Therapy a Reality for Patients: An Interview With Allogene Therapeutics
Industry InsightTechnology Networks spoke with David Chang, MD, PhD, President, Chief Executive Officer and Co-Founder of Allogene to learn about the recent developments in the fast-developing allogeneic cell therapy research space and Allogene's visions for the future.
Read More
Leading the Movement Towards Direct Cell Conversion: An Interview With Mogrify
Industry InsightTechnology Networks recently spoke with Joe Foster, COO, Mogrify, to learn about the biotech company's proprietary platform, the challenges encountered in developing cell therapies and to gain Mogrify's insights on the future of this exciting research space.
Read More
Looking to the Future of Cell and Gene Therapies
Industry InsightTechnology Networks recently spoke with three of the leaders in the cell and gene therapy space, Allogene Therapeutics, bluebird Bio and Mogrify to gain their insights on the next developments in this space.
Read More
Cellular Agriculture – Moving Towards a More Sustainable Method of Milk Production
Industry InsightAs part of efforts to provide a more sustainable method of milk production, TurtleTree Labs has developed a cellular method, which bypasses the environmental and animal welfare issues of industrial dairy. Technology Networks recently spoke with Fengru Lin, the founder of TurtleTree Labs, to learn more about the method and the benefits it could offer.
Read More
Proteomics Lends a Hand in the Fight Against COVID-19
Industry InsightTechnology Networks spoke with Stephen Williams, Chief Medical Officer of SomaLogic, to learn about how proteomics can contribute to the fight against COVID-19 and the availability of the SomaScan Assay at this critical time.
Read More
Maintaining Optimal Blood Volume in COVID-19 Patients
Industry InsightTechnology Networks spoke to Michael Feldschuh, CEO, Daxor, to learn more about the importance of maintaining optimal blood volume, how the BVA-100 test can help to measure this, and how clinicians can use the information it provides to guide treatment of COVID-19 patients.
Read More
Scale and Speed in Proteomics Data Processing
Industry InsightTargeted proteomics start-up ProteiQ Biosciences recently announced the launch of InfineQ, its cloud-based solution software for near real-time processing of proteomics data. Technology Networks spoke with Arnoud Groen, CSO and co-founder of ProteiQ, to learn more about the solution and how it provides the scale and speed required for biomarker discovery.
Read More
Less Time Managing Inventory, More Time at the Bench? Yes Please
Industry InsightLab efficiency is critical to speeding up development processes, yet many researchers find they spend more time managing consumables data than working at the bench. Lab informatics is one solution to this problem.
Read More
Blood Analysis in a COVID-19 Quarantine Lab
Industry InsightTechnology Networks spoke with Yossi Pollak, CEO, Sight Diagnostics, to learn more about OLO and how it is being used to minimize the challenges of handling and analyzing blood samples from COVID-19 infected patients.
Read More
